US Congress Senate Bill 252 (Prior Session Legislation)

---

Spectrum: Moderate Partisan Bill (Democrat 14-2)
Status: Introduced on February 1 2017 - 25% progression, died in committee
Action: 2017-02-01 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Medicare Drug Savings Act of 2017 This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan (PDP). Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.

Medicare Drug Savings Act of 2017

Sen. Bill Nelson [D-FL]	Sen. Patrick Leahy [D-VT]	Sen. Richard Durbin [D-IL]	Sen. Angus King [I-ME]
Sen. Jack Reed [D-RI]	Sen. Richard Blumenthal [D-CT]	Sen. Sherrod Brown [D-OH]	Sen. Debbie Stabenow [D-MI]
Sen. Bernard Sanders [I-VT]	Sen. Tammy Baldwin [D-WI]	Sen. Mazie Hirono [D-HI]	Sen. Tom Udall [D-NM]
Sen. Al Franken [D-MN]	Sen. Amy Klobuchar [D-MN]	Sen. Sheldon Whitehouse [D-RI]	Sen. Jeanne Shaheen [D-NH]

Date	Chamber	Action
2017-02-01	Senate	Read twice and referred to the Committee on Finance.

SB1511 (Related) 2017-06-29 - Read twice and referred to the Committee on Finance.
HB1776 (Related) 2017-04-05 - Referred to the Subcommittee on Health.
SB771 (Related) 2017-03-29 - Read twice and referred to the Committee on Finance.
HB4138 (Related) 2017-10-27 - Referred to the Subcommittee on Health.
SB3411 (Related) 2018-09-05 - Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/115th-congress/senate-bill/252/all-info
Text	https://www.congress.gov/115/bills/s252/BILLS-115s252is.pdf